As medical costs continue to rise, health care insurers are taking a fresh look at medical management to contain costs. With today’s approaches more sophisticated, insurers and their health plans must make carefully balanced strategic choices to derive competitive advantage by enhancing their capabilities in this area. In this report, BCG reviews the various medical management strategies that different plans are adopting and the critical issues that will determine success or failure for the health plans placing those bets.
Why has the JDRF denied funding to Dr. Faustman and her research to cure Type 1 diabetes? Phase 1 has become the burden of proof that the “Faustman Hypothesis” is the frontiers we must explore to cure type 1 diabetes and other autoimmune diseases. JDRF – if you’re not part of the solution you are part of the problem! Here’s my call to action: Phase 2 of Dr. Faustman’s human trials are estimated to cost $25 million. If 1 million people watching this video have the wherewithal to donate $25 to Dr. Faustman’s human trials at MGH – the cure for millions is unstoppable! Do you have $25 to make a dream come true? Please donate to Dr. Faustman’s research
Campaign Projects Podcast 
Leave a comment